15,009 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Purchased by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. acquired a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,009 shares of the company’s stock, valued at approximately $42,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Fielder Capital Group LLC purchased a new stake in shares of ASP Isotopes during the 2nd quarter valued at approximately $55,000. The Manufacturers Life Insurance Company bought a new position in ASP Isotopes during the third quarter valued at approximately $52,000. KKM Financial LLC grew its holdings in shares of ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after purchasing an additional 9,000 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in ASP Isotopes in the 3rd quarter worth $66,000. Finally, MetLife Investment Management LLC bought a new stake in ASP Isotopes in the third quarter worth $88,000. Institutional investors own 16.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ASPI shares. Canaccord Genuity Group reiterated a “buy” rating and issued a $4.50 price objective on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group initiated coverage on ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Price Performance

ASPI stock opened at $4.89 on Monday. The stock has a market capitalization of $349.10 million, a price-to-earnings ratio of -8.02 and a beta of 3.27. The firm’s 50-day moving average price is $5.83 and its two-hundred day moving average price is $3.90. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 12-month low of $1.65 and a 12-month high of $9.33.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.